Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson’s disease
2014 · Cell Death and Disease · 54 citations
https://doi.org/10.1038/cddis.2014.333
A
Amàlia Lafuente
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
159
Papers
3.0K
Citations
32
h-index
89
i10-index
Amàlia Lafuente is an academic researcher from University of the Basque Country. The author has contributed to research in topics: Schizophrenia research and treatment & Bipolar Disorder and Treatment & Obsessive-Compulsive Spectrum Disorders. The author has an h-index of 32, co-authored 136 publications.
Papers by this author
worksEpigenetic and genetic variants in the HTR1B gene and clinical improvement in children and adolescents treated with fluoxetine
2016 · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 37 citations
https://doi.org/10.1016/j.pnpbp.2016.12.003
Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes
2016 · The Pharmacogenomics Journal · 36 citations
https://doi.org/10.1038/tpj.2016.44
Plasma Fluoxetine Concentrations and Clinical Improvement in an Adolescent Sample Diagnosed With Major Depressive Disorder, Obsessive-Compulsive Disorder, or Generalized Anxiety Disorder
2014 · Journal of Clinical Psychopharmacology · 27 citations
https://doi.org/10.1097/jcp.0000000000000121
Satisfaction survey with DNA cards method to collect genetic samples for pharmacogenetics studies
2006 · BMC Medical Genetics · 13 citations
https://doi.org/10.1186/1471-2350-7-45
Author Correction: Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics
2019 · Translational Psychiatry · 0 citations
https://doi.org/10.1038/s41398-019-0480-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat